Atlas Arteria (OTCMKTS:MAQAF) Stock Price Down 16.3% – What’s Next?

Atlas Arteria Limited (OTCMKTS:MAQAF)’s stock price fell 16.3% during mid-day trading on Tuesday . The stock traded as low as $3.08 and last traded at $3.08. Approximately 200 shares traded hands during mid-day trading, a decline of 84% from the average daily volume of 1,235 shares. The stock had previously closed at $3.68.

Analyst Ratings Changes

A number of equities research analysts recently commented on the company. Royal Bank Of Canada lowered Atlas Arteria to an “underperform” rating and set a $4.75 target price on the stock. in a research report on Thursday, July 2nd. Jefferies Financial Group raised shares of Atlas Arteria to a “buy” rating and set a $5.31 price target for the company in a research report on Thursday, August 27th. One analyst has rated the stock with a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $5.03.

Atlas Arteria Price Performance

The firm’s fifty day simple moving average is $3.47 and its 200 day simple moving average is $3.38.

Atlas Arteria Company Profile

Atlas Arteria (OTCMKTS: MAQAF) is a global toll road owner and operator specializing in the development, management and long-term investment of transport infrastructure. The company partners with governments and institutional investors to acquire, manage and optimise concession-based road assets, generating stable revenue streams through user fees and toll collections. Atlas Arteria focuses on enhancing traffic flow and safety through targeted capital improvements and operational efficiencies across its portfolio.

The company’s primary assets span North America, Europe and Australia.